Browse > Article
http://dx.doi.org/10.4014/jmb.0911.11002

Comparative Study on Characterization of Recombinant B Subunit of E. coli Heat-Labile Enterotoxin (rLTB) Prepared from E. coli and P. pastoris  

Ma, Xingyuan (State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology)
Yao, Bi (State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology)
Zheng, Wenyun (State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology)
Li, Linfeng (State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology)
Publication Information
Journal of Microbiology and Biotechnology / v.20, no.3, 2010 , pp. 550-557 More about this Journal
Abstract
Escherichia coli (E. coli) heat-labile enterotoxin B subunit (LTB) was regarded as one of the most powerful mucosal immunoadjuvants eliciting strong immunoresponse to coadministered antigens. In the research, the high-level secretory expression of functional LTB was achieved in P. pastoris through high-density fermentation in a 5-1 fermentor. Meanwhile, the protein was expressed in E. coli by the way of inclusion body, although the gene was cloned from E. coli. Some positive yeast and E. coli transformants were obtained respectively by a series of screenings and identifications. Fusion proteins LTB-6$\times$His could be secreted into the supernatant of the medium after the recombinant P. pastoris was induced by 0.5% (v/v) methanol at $30^{\circ}C$, whereas E. coli transformants expressed target protein in inclusion body after being induced by 1 mM IPTG at $37^{\circ}C$. The expression level increased dramatically to 250-300 mg/l supernatant of fermentation in the former and 80-100 mg/l in the latter. The LTB-6$\times$His were purified to 95% purity by affinity chromatography and characterized by SDS-PAGE and Western blot. Adjuvant activity of target protein was analyzed by binding ability with GMI gangliosides. The MW of LTB-6$\times$His expressed in P. pastoris was greater than that in E. coli, which was equal to the expected 11 kDa, possibly resulted from glycosylation by P. pastoris that would enhance the immunogenicity of co-administered antigens. These data demonstrated that P. pastoris producing heterologous LTB has significant advantages in higher expression level and in adjuvant activity compared with the homologous E. coli system.
Keywords
rLTB; characterization; expression and purification; P. patoris; E. coli;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
연도 인용수 순위
1 Ruitenberg, K. M., J. R. Gilkerson, J. E. Wellington, D. N. Love, and J. M. Whalley. 2001. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease. Virus Res. 79: 125-135.   DOI
2 Stoscheck, C. M. 1990. Quantitation of protein. Methods Enz. 182: 50-68.   DOI
3 Green, E. A., C. Botting, H. M. Webb, T. R. Hirst, and R. E. Randall. 1996. Construction, purification and immunogenicity of antigen-antibody-LTB complexes. Vaccine 14: 949-458.   DOI   ScienceOn
4 Isaka, M., T. Komiya, M. Takahashi, Y. Yasuda, T. Taniguchi, Y. Zhao, et al. 2004. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine. Vaccine 22: 3061-3068.   DOI   ScienceOn
5 Verweij, W. R., L. de Haan, M. Holtrop, E. Agsteribbe, R. Brands, G. J. van Scharrenburg, and J. Wilschut. 1998. Mucosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 16: 2069-2076.   DOI   ScienceOn
6 Pizza, M., M. M. Giuliani, M. R. Fontana, E. Monaci, G. Douce, G. Dougan, K. H. Mills, R. Rappuoli, and G. Del Giudice. 2001. Mucosal vaccines: Non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19: 2534-2541.   DOI   ScienceOn
7 Richards, C. M., A. T. Aman, T. R. Hirst, T. J. Hill, and N. A. Williams. 2001. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 75: 1664-1671.   DOI   ScienceOn
8 Tschopp, J. F., G. Sverlow, R. Kosson, W. Craig, and L. Grinna. 1987. High-level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris. BioTechnology 5: 1305-1308.   DOI
9 Ma, X., W. Zheng, T. Wang, D. Wei, and Y. Ma. 2006. Optimization and high-level expression of a functional GSTtagged rHLT-B in Escherichia coli and GM1 binding ability of purified rHLT-B. J. Microbiol. 44: 293-300.
10 Holmgren, J., M. Lindblad, P. Fredman, L. Svennerholm, and H. Myrvold. 1985. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 89: 27-35.
11 Cregg, J. M., T. S. Vedvick, and W. C. Raschke. 1993. Recent advances in the expression of foreign genes in Pichia pastoris. BioTechnology 11: 905-910.   DOI   ScienceOn
12 Rezaee, M. A., A. Rezaee, S. M. Moazzeni, A. H. Salmanian, Y. Yasuda, K. Tochikubo, S. N. Pirayeh, and M. Arzanlou. 2005. Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in Saccharomyces cerevisiae. J. Microbiol. 43: 354-360.
13 Scorer, C. A., J. J. Clare, W. R. McCombie, M. A. Romanos, and K. Sreekrishna. 1994. Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. BioTechnology 12: 181-184.   DOI   ScienceOn
14 Feil, I. K., R. Reddy, L. de Haan, E. A. Merritt, F. van den Akker, D. R. Storm, and W. G. Hol. 1996. Protein engineering studies of A-chain loop 47-56 of Escherichia coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity. Mol. Microbiol. 20: 823-832.   DOI   ScienceOn
15 Kozuka, S., Y. Yasuda, M. Isaka, N. Masaki, T. Taniguchi, K. Matano, et al. 2000. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity. Vaccine 18: 1730-1737.   DOI   ScienceOn
16 Douce, G., M. Fontana, M. Pizza, R. Rappuoli, and G. Dougan. 1997. Intranasal immunogenicity and adjuvanticity of sitedirected mutant derivatives of cholera toxin. Infect. Immun. 65: 2821-2828.
17 Nashar, T. O., H. M. Webb, S. Eaglestone, N. A. Williams, and T. R. Hirst. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad Sci. U.S.A. 93: 226-230.   DOI   ScienceOn
18 Fingerut, E., B. Gutter, R. Meir, D. Eliahoo, and J. Pitcovski. 2005. Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast. Vaccine 23: 4685-4996.   DOI   ScienceOn
19 Sagt, C. M., B. Kleizen, R. Verwaal, M. D. de Jong, W. H. Muller, A. Smits, et al. 2000. Introduction of an N-glycosylation site increases secretion of heterologous proteins in yeasts. Appl. Environ. Microbiol. 66: 4940-4944.   DOI   ScienceOn
20 Millar, D. G., T. R. Hirst, and D. P. Snider. 2001. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its closely related homologue, the B subunit of cholera toxin. Infect Immun. 69: 3476-3482.   DOI   ScienceOn
21 Sreekrishna, K., L. Nelles, R. Potenz, J. Cruze, P. Mazzaferro, W. Fish, et al. 1989. High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris. Biochemistry 28: 4117-4125.   DOI   ScienceOn
22 Isaka, M., Y. Yasuda, S. Kozuka, T. Taniguchi, Y. Miura, K. Matano, N. Goto, and K. Tochikubo. 1999. Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid. Vaccine 17: 944-948.   DOI   ScienceOn
23 Takahashi, I., H. Kiyono, R. J. Jackson, K. Fujihashi, H. F. Staats, S. Hamada, J. D. Clements, K. L. Bost, and J. R. McGhee. 1996. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect. Immun. 64: 1290-1298.
24 Amin, T. and T. R. Hirst. 1994. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Protein Expr. Purif. 5: 198-204.   DOI   ScienceOn
25 de Haan, L., W. R. Verweij, I. K. Feil, M. Holtrop, W. G. Hol, E. Agsteribbe, and J. Wilschut. 1998. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology 94: 424-430.   DOI   ScienceOn
26 Sixma, T. K., S. E. Pronk, K. H. Kalk, E. S. Wartna, B. A. van Zanten, B. Witholt, and W. G. Hol. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351: 371-377.   DOI   ScienceOn
27 Cregg, J. M., J. F. Tschopp, C. Stillman, R. Siegel, M. Akong, W. S. Craig, et al. 1987. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris. BioTechnology 5: 479-485.   DOI
28 Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. U.S.A. 92: 1644-1648.   DOI   ScienceOn